HAL — Halliburton Company

The tape is constructive but not euphoric. Q3 2026 delivered adjusted EPS of $0.60 versus $0.58 consensus and revenue of $5.70B versus $5.58B, and management guided 2027 to mid-single-digit revenue growth with ~15% operating margins (+200bps). International strength (Latin America +13%, Europe/Africa +23% YoY) offsets an 8.6% North American revenue decline. Still, the stock is -12.7% over six months and sits below its 200-day average, so the Street's 'Buy' consensus and ~$43 target reflect hope in a recovery the price has not yet embraced.

Revenue has been essentially flat for three years, oscillating between roughly $5.4B and $5.8B per quarter (Q3 2026: $5.70B). The real story is margin compression: operating margin fell from ~17-18% through 2024 (Q2 2024: 17.7%; Q4 2023: 18.4%) to ~11-13% in 2026 (Q3 2026: 10.9%; Q2 2026: 13.6%). Diluted EPS peaked at $0.80 in Q2 2024 and has run $0.50-$0.64 through 2026. Two quarters were distorted by charges — Q3 2025 net income of just $18M (EPS $0.021) and a weak Q1 2025 ($0.24) — so the trough is partly accounting noise, but the directional decline in margins is real. The trend is decelerating-then-stabilizing, not structurally broken; management's 2027 target of +200bps is the swing factor.

Cheap-to-fair versus its own history, not deeply discounted. TTM P/E of 13.9x sits below the 5-year average of 15.5x; forward P/E is ~14.2x on the $2.339 next-FY EPS estimate, which is actually below TTM EPS of $2.408 — analysts are modeling continued softness. P/S of 1.23x is modestly below the 5-year 1.32x, and EV/EBITDA of 8.4x is reasonable for oilfield services. The 0.24 PEG looks optically cheap but is an artifact of a depressed growth denominator. A 5.8% TTM FCF yield and 1.8% dividend add a valuation floor.

At $33.28 the market is pricing in flat-to-soft North American completions and only partial margin recovery — forward EPS estimates sit below trailing, so the stock is not paying up for management's 2027 optimism. If the 15% operating-margin target is achieved, normalized earnings power could reach $2.75-$3.00+, which at 15x implies $40+. If North America stays flat and margins stay near 12%, ~$2.40 in EPS caps the upside. The setup is asymmetric only if you believe the international-led margin recovery; otherwise it is fairly valued.

As of 2026-10-20, RSI stood at 51.1 (neutral, neither oversold nor overbought). Price was +2.26% above the 20-day SMA, -2.41% below the 50-day, and -6.75% below the 200-day, with a -12.71% six-month return. That is a range-bound chart with a mild medium-term downtrend and a short-term bounce — no technical edge either way. Support sits near the 52-week low of $24.12, resistance near the $43.59 high; RSI at 51 means a buyer gets no 'oversold' discount.

• U.S. onshore frac activity is flat and pressure-pumping pricing is muted, a direct drag on Completion and Production revenue and margins.
• International and offshore markets are the tailwind — strong tendering in Latin America, the Middle East, and offshore Europe/Africa from NOCs and supermajors with disciplined but robust deepwater budgets.
• Oil and gas price volatility keeps E&P capital spending cautious, capping the pace of any North American recovery.
• Higher-for-longer interest rates raise upstream cost of capital and pressure capital-return decisions across the sector.
• Geopolitical exposure — new Venezuela MOUs (Eneva, WESCA) carry sanctions and political risk even as they add optionality.

• Delivery against the 2027 guide of mid-single-digit revenue growth and ~15% operating margins (+200bps) — the single biggest swing factor for earnings.
• Execution on newly won international work: bp's Brazil deepwater appraisal, Eni's bundled well-construction award in Cyprus, and the Venezuela MOUs.
• A recovery in U.S. onshore completion activity if commodity prices firm, which would restore pressure-pumping pricing.
• Continued share repurchases and the ~1.8% dividend supporting the shareholder-return story.

• Prolonged North American pressure-pumping oversupply and further pricing erosion, keeping the region a structural drag.
• A drop in oil/gas prices triggering E&P capex cuts and delaying the international spending cycle.
• Execution and geopolitical risk on international contracts, particularly Venezuela sanctions exposure.
• The 2027 margin-recovery target proving optimistic, leaving EPS stuck near $2.40 and the stock fairly-to-fully valued.

Halliburton is a solid, cash-generative oilfield-services franchise trading near fair value at a cyclical low in its North American business. The balance sheet is strong (D/E 0.74, current ratio 2.0), free cash flow is running ~$1.6B TTM, and international strength plus a credible 2027 margin target offer real upside — but North America is the swing factor and shows no near-term inflection. This is a hold-and-watch story, not a compelling buy at current levels; the risk/reward improves meaningfully if margins begin to recover.

Applied a 15x P/E — slightly below the 5-year average of 15.5x to reflect the current margin-compression cycle but above the 13.9x TTM to price in recovery — to a normalized forward adjusted EPS of ~$2.47, yielding ~$37. Cross-checked against 8.5x forward EBITDA (~$4.1B) less ~$5.2B net debt, which implies roughly $36, confirming the ~$37 estimate.